Drug Delivery Products

Gains will be driven by dosages that better treat autoimmune, cancer, cardiovascular, neurological, viral, and other debilitating disorders, and by devices that are safer, prevent infection and are easier to use.

US demand to reach $251 billion in 2019

US demand for drug delivery products is forecast to grow 6.1 percent annually to $251 billion in 2019. Specialized dosage formulations that improve therapies for autoimmune, cancer, cardiovascular, neurological, viral, and other debilitating disorders will lead gains. Included in this group are human and humanized monoclonal antibodies, polymer-encapsulated medicines, and brachytherapy seeds. Among drug delivery devices, pen injectors and retractable prefillable syringes will record the fastest revenue growth based on safety, infection prevention, and ease-of-use advantages. Demand for oral drug delivery products will benefit from bioavailability and reduced dosing advantages, while controlled-release formulations will continue to dominate revenues. On the downside, patent expirations and generic competition will soften overall growth potential for this product segment.

Prefillable syringes to lead strong gains in parenteral drug delivery

US demand for parenteral drug delivery products is projected to post double-digit gains through 2019. Advances in monoclonal antibodies and polymer-encapsulated medicines will underlie growth. The use of new and existing therapies based on human and humanized monoclonal antibodies will improve the effectiveness of remedies against various forms of cancer and other long-term disorders, such as allergy-linked asthma, Crohn’s disease, rheumatoid and psoriatic arthritis, and wet age-related macular degeneration. Enhanced bioavailability and reduced toxicity advantages will boost applications for polymer-enhanced medicines in the treatment of conditions such as cancer complications, hepatitis B and C, and multiple sclerosis. Among parenteral delivery devices, prefillable syringes will account for the largest and fastest expanding demand over the long term. Improvements in safety features such as automatic needle retraction, along with overall infection prevention and response time advantages, will benefit growth. Prefillable syringes will also broaden self-use applications based on advances in pen injectors and related apparatus.

Mixed outlook for inhalers

Demand for other drug delivery products is expected to surpass $34 billion in 2019. Dry powder and metered dose inhalers will account for more than three-fourths of revenues, reflecting upward trends in prevalence of asthma and chronic obstructive pulmonary disease (COPD). On the downside, growth prospects for inhalers will weaken gradually as patent expirations make several widely used respiratory therapies -- such as ADVAIR, SPIRIVA and SYMBICORT -- available to low cost generic competition. Limited indications and competition from alternative therapies will hold down demand for transdermal drug delivery products. Within this product group, overactive bladder and estrogen replacement therapies will post the fastest revenue growth. Contraceptive inserts will draw the largest and fastest expanding revenues among implantable drug delivery products based on convenience and effectiveness advantages in birth control applications. Brachytherapy implants will also fare well in the marketplace, spurred by increasing use in cervical, prostate, breast, and skin cancer treatment. Im-plantable drug pumps will see moderate growth in demand as improvements in device safety broadens applications in the delivery of pain control and ophthalmic medication. Recent introductions and a rise in heart conditions will foster growth in the market for drug-eluting stents.

Study coverage

This study analyzes the $187 billion US drug delivery system industry. It presents historical demand data (2004, 2009 and 2014) and forecasts (2019 and 2024) by product (e.g., oral, parenteral, inhalation, transdermal, implantable) and application (e.g., central nervous system, hormones, respiratory, anti-infective, cardiovascular, gastrointestinal, nutritional). The study also considers market environment factors, details industry structure, evaluates company market share, and profiles 30 industry players, including Gilead Sciences, Roche, and Johnson & Johnson.

Back to Top

Purchase Drug Delivery Products by the Section

  1. Drug Delivery Products

    $5,300.00

    1. 1 INTRODUCTION

      $94.00

    2. 2 EXECUTIVE SUMMARY

      $116.00

      1. Table | DRUG DELIVERY PRODUCT DEMAND

    3. 3 MARKET ENVIRONMENT

      $1,622.00

      1. 3.1 General

        $82.00

      2. 3.2 Economic Factors

        $174.00

        1. Table | MACROECONOMIC INDICATORS

      3. 3.3 Demographic Patterns

        $112.00

        1. Table | RESIDENT POPULATION BY AGE GROUP

      4. 3.4 Healthcare Trends

        $791.00

        1. 3.4.1 Health Insurance Reforms

          $110.00

          1. Table | HEALTH INSURANCE COVERAGE OF THE US POPULATION, 2004-2014

        2. 3.4.2 Medical Conditions

          $160.00

          1. Table | ACUTE CONDITIONS BY TYPE

          2. Table | CHRONIC CONDITIONS BY TYPE

        3. 3.4.3 National Health Expenditures

          $259.00

          1. Table | NATIONAL HEALTH EXPENDITURES BY SPENDING CATEGORY

          2. Table | NATIONAL HEALTH EXPENDITURES BY FUNDING SOURCE

        4. 3.4.4 Medical Providers

          $139.00

          1. Table | MEDICAL PROVIDERS BY TYPE

        5. 3.4.5 Patient Activity

          $106.00

          1. Table | PATIENT ACTIVITY BY TYPE

      5. 3.5 Pharmaceutical Industry Overview

        $508.00

        1. 3.5.1 Regulation

          $99.00

        2. 3.5.2 Research & Development

          $82.00

        3. 3.5.3 Product Demand

          $316.00

          1. Table | PHARMACEUTICAL DEMAND BY THERAPEUTIC CLASS

          2. Table | PHARMACEUTICAL DEMAND BY DOSAGE FORMULATION

          3. Table | PHARMACEUTICAL DEMAND BY REGULATORY CLASSIFICATION

          4. Table | PHARMACEUTICAL DEMAND BY PATENT STATUS

    4. 4 DRUG DELIVERY PRODUCT OVERVIEW

      $339.00

      1. 4.1 General

        $82.00

        1. Table | DRUG DELIVERY PRODUCT DEMAND BY TYPE

      2. 4.2 Types of Drug Delivery Products

        $86.00

        1. CHART III-1 DRUG DELIVERY PRODUCT DEMAND BY TYPE, 2014

      3. 4.3 Historical Market Trends

        $82.00

        1. Table | DRUG DELIVERY PRODUCT DEMAND PATTERNS, 2004-2014

      4. 4.4 US Trade

        $82.00

        1. Table | US TRADE IN DRUG DELIVERY PRODUCTS

      5. 4.5 International Markets

        $82.00

        1. Table | WORLD DRUG DELIVERY PRODUCT DEMAND BY REGION

    5. 5 ORAL DRUG DELIVERY PRODUCTS

      $892.00

      1. 5.1 General

        $82.00

        1. Table | ORAL DRUG DELIVERY PRODUCT DEMAND BY TYPE

      2. 5.2 Controlled-Release Formulations

        $385.00

        1. Table | CONTROLLED-RELEASE ORAL DRUG DELIVERY PRODUCT DEMAND

        2. 5.2.1 Film-Coated Formulations

          $131.00

          1. Table | FILM-COATED ORAL DRUG DELIVERY PRODUCT DEMAND

        3. 5.2.2 Diffusion Formulations

          $86.00

          1. Table | DIFFUSION ORAL DRUG DELIVERY PRODUCT DEMAND

        4. 5.2.3 Reservoir Formulations

          $82.00

          1. Table | RESERVOIR ORAL DRUG DELIVERY PRODUCT DEMAND

      3. 5.3 Chewable Tablets

        $82.00

        1. Table | CHEWABLE TABLET PRODUCT DEMAND BY THERAPEUTIC CLASS

      4. 5.4 Orally Disintegrating Tablets

        $107.00

        1. Table | ORALLY DISINTEGRATING TABLET DEMAND BY THERAPEUTIC CLASS

      5. 5.5 Nanoparticulate Formulations

        $147.00

        1. Table | ORAL NANOPARTICULATE DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS

      6. 5.6 Transmucosal Formulations

        $113.00

        1. Table | TRANSMUCOSAL DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS

    6. 6 PARENTERAL DRUG DELIVERY PRODUCTS

      $2,044.00

      1. 6.1 General

        $82.00

        1. Table | PARENTERAL DRUG DELIVERY PRODUCT DEMAND BY TYPE

        2. CHART V-1 PARENTERAL DRUG DELIVERY PRODUCT DEMAND BY TYPE, 2014

      2. 6.2 Therapeutic Monoclonal Antibodies

        $686.00

        1. Table | THERAPEUTIC MONOCLONAL ANTIBODY DEMAND BY THERAPEUTIC CLASS

        2. 6.2.1 Technology

          $82.00

        3. 6.2.2 Products

          $555.00

      3. 6.3 Encapsulated Parenteral Formulations

        $510.00

        1. Table | ENCAPSULATED PARENTERAL PRODUCT DEMAND BY TYPE & THERAPEUTIC CLASS

        2. 6.3.1 Polymer-Protected Formulations

          $293.00

        3. 6.3.2 Liposomes

          $187.00

      4. 6.4 Infusion Products

        $333.00

        1. Table | INFUSION PRODUCT DEMAND BY TYPE

        2. 6.4.1 IV Administration Sets

          $82.00

        3. 6.4.2 Premixed IV Solutions

          $82.00

        4. 6.4.3 Infusion Pumps

          $84.00

        5. 6.4.4 Other Infusion Products

          $82.00

      5. 6.5 Parenteral Devices

        $451.00

        1. Table | PARENTERAL DEVICE DEMAND BY TYPE

        2. 6.5.1 Prefillable Syringes

          $247.00

        3. 6.5.2 Hypodermic Syringes

          $82.00

        4. 6.5.3 IV Catheters

          $82.00

        5. 6.5.4 Other Parenteral Devices

          $82.00

    7. 7 OTHER DRUG DELIVERY PRODUCTS

      $1,120.00

      1. 7.1 General

        $82.00

        1. Table | OTHER DRUG DELIVERY PRODUCT DEMAND BY TYPE

      2. 7.2 Inhalation Drug Delivery Products

        $250.00

        1. Table | INHALATION DRUG DELIVERY PRODUCT DEMAND BY TYPE

        2. 7.2.1 Dry Powder Formulations

          $92.00

          1. Table | DRY POWDER INHALER DEMAND

        3. 7.2.2 Metered Dose Formulations

          $125.00

          1. Table | METERED DOSE INHALER DEMAND

      3. 7.3 Transdermal Drug Delivery Products

        $405.00

        1. Table | TRANSDERMAL DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS

        2. 7.3.1 Transdermal Technologies

          $82.00

        3. 7.3.2 Central Nervous System Agents

          $157.00

        4. 7.3.3 Hormones & Related Agents

          $99.00

        5. 7.3.4 Cardiovascular Agents

          $82.00

        6. 7.3.5 Other Transdermal Patches

          $82.00

      4. 7.4 Implantable Drug Delivery Products

        $412.00

        1. Table | IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE

        2. 7.4.1 Drug Inserts

          $103.00

          1. Table | DRUG INSERT DEMAND BY THERAPEUTIC CLASS

        3. 7.4.2 Drug-Eluting Stents

          $106.00

          1. Table | DRUG-ELUTING STENT DEMAND

        4. 7.4.3 Other Implantable Drug Delivery Products

          $175.00

          1. Table | OTHER IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE

    8. 8 APPLICATIONS

      $1,726.00

      1. 8.1 General

        $82.00

        1. Table | DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS

        2. CHART VII-1 DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS, 2014

      2. 8.2 Central Nervous System Agents

        $306.00

        1. Table | CENTRAL NERVOUS SYSTEM DRUG DELIVERY PRODUCT DEMAND BY TYPE

        2. 8.2.1 Controlled-Release Formulations

          $82.00

        3. 8.2.2 Other Oral Drug Delivery Products

          $82.00

        4. 8.2.3 Transdermal Formulations

          $89.00

        5. 8.2.4 Monoclonal Antibodies & Polymer Encapsulated Therapies

          $82.00

        6. 8.2.5 Liposomes

          $82.00

        7. 8.2.6 Other Drug Delivery Products

          $82.00

      3. 8.3 Hormones & Related Agents

        $555.00

        1. Table | HORMONE & RELATED DRUG DELIVERY PRODUCT DEMAND BY TYPE

        2. 8.3.1 Anticancer Monoclonal Antibodies

          $175.00

        3. 8.3.2 Encapsulated Polymers

          $82.00

        4. 8.3.3 Liposomes

          $82.00

        5. 8.3.4 Insulin Pen Injectors

          $82.00

        6. 8.3.5 Controlled-Release & Other Oral Drug Delivery Products

          $82.00

        7. 8.3.6 Transdermal Hormones & Related Agents

          $82.00

        8. 8.3.7 Other Drug Delivery Products

          $82.00

      4. 8.4 Respiratory Agents

        $229.00

        1. Table | RESPIRATORY DRUG DELIVERY PRODUCT DEMAND BY TYPE

        2. 8.4.1 Dry Powder Inhalers

          $82.00

        3. 8.4.2 Metered Dose Inhalers

          $82.00

        4. 8.4.3 Monoclonal Antibodies

          $82.00

      5. 8.5 Anti-Infective Agents

        $82.00

        1. Table | ANTI-INFECTIVE DRUG DELIVERY PRODUCT DEMAND BY TYPE

      6. 8.6 Cardiovascular Agents

        $194.00

        1. Table | CARDIOVASCULAR DRUG DELIVERY PRODUCT DEMAND BY TYPE

        2. 8.6.1 Controlled-Release Formulations

          $82.00

        3. 8.6.2 Monoclonal Antibodies

          $82.00

        4. 8.6.3 Drug-Eluting Stents

          $82.00

        5. 8.6.4 Transdermal Patches

          $82.00

      7. 8.7 Gastrointestinal Agents

        $122.00

        1. Table | GASTROINTESTINAL DRUG DELIVERY PRODUCT DEMAND BY TYPE

      8. 8.8 Nutritional Agents

        $82.00

        1. Table | NUTRITIONAL PREPARATION DELIVERY PRODUCT DEMAND BY TYPE

      9. 8.9 Other Pharmaceuticals

        $150.00

        1. Table | OTHER APPLICATION DRUG DELIVERY PRODUCT DEMAND BY TYPE

    9. 9 INDUSTRY STRUCTURE

      $5,333.00

      1. 9.1 General

        $82.00

        1. Table | US DRUG DELIVERY PRODUCT SALES BY COMPANY, 2014

      2. 9.2 Market Share

        $95.00

        1. CHART VIII-1 DRUG DELIVERY FORMULATIONS, US MARKET SHARE, 2014

        2. CHART VIII-2 DRUG DELIVERY DEVICES, US MARKET SHARE, 2014

      3. 9.3 Competitive Strategies

        $82.00

      4. 9.4 Mergers & Acquisitions

        $84.00

        1. Table | SELECTED ACQUISITIONS & DIVESTITURES

      5. 9.5 Licensing & Related Agreements

        $158.00

        1. Table | SELECTED COOPERATIVE AGREEMENTS

      6. 9.6 Marketing & Distribution

        $82.00

      7. 9.7 Manufacturing

        $82.00

      8. 9.8 Company Profiles

        $5,333.00

        1. 9.8.1 Abbott Laboratories

          $130.00

        2. 9.8.2 AbbVie Incorporated

          $124.00

        3. 9.8.3 Adare Pharmaceuticals Incorporated

          $178.00

        4. 9.8.4 Allergan plc

          $269.00

        5. 9.8.5 Amgen Incorporated

          $167.00

        6. 9.8.6 AptarGroup Incorporated

          $142.00

        7. 9.8.7 AstraZeneca plc

          $231.00

        8. 9.8.8 Baxter International Incorporated

          $164.00

        9. 9.8.9 Becton, Dickinson, and Company

          $414.00

        10. 9.8.10 Boehringer Ingelheim GmbH

          $148.00

        11. 9.8.11 Braun (B.) Melsungen AG

          $171.00

        12. 9.8.12 Bristol-Myers Squibb Company

          $158.00

        13. 9.8.13 Evonik Industries AG

          $126.00

        14. 9.8.14 Gerresheimer AG

          $182.00

        15. 9.8.15 Gilead Sciences Incorporated

          $113.00

        16. 9.8.16 GlaxoSmithKline plc

          $265.00

        17. 9.8.17 Johnson & Johnson

          $270.00

        18. 9.8.18 Lilly (Eli) and Company

          $239.00

        19. 9.8.19 Merck & Company Incorporated

          $256.00

        20. 9.8.20 Nitto Denko Corporation

          $132.00

        21. 9.8.21 Novartis AG

          $378.00

        22. 9.8.22 Novo Nordisk A/S

          $140.00

        23. 9.8.23 Pfizer Incorporated

          $450.00

        24. 9.8.24 Roche Holding Limited

          $241.00

        25. 9.8.25 Sanofi

          $266.00

        26. 9.8.26 Teva Pharmaceutical Industries Limited

          $234.00

        27. 9.8.27 3M Company

          $220.00

        28. 9.8.28 Unilife Corporation

          $226.00

        29. 9.8.29 Vetter Pharma International GmbH

          $110.00

        30. 9.8.30 West Pharmaceutical Services Incorporated

          $149.00

      9. 9.9 Additional Companies in the Drug Delivery Product Market

        $82.00

Back to Top